Sola Diagnostics was founded by Professor Martin Widschwendter (UCL EGA Institute for Women’s Health and University of Innsbruck), in 2020 to develop epigenetic tests for precision prevention of women’s cancers. To date, Sola have launched the WID®-easy test, a diagnostic test for womb cancer which prevents unnecessary invasive diagnostic procedures.